C8orf13/BLK Association with Systemic Lupus Erythematosus Across Different Ethnicities (136.28)

Rufei Lu,Niurka González Domínguez,Chris Lessard,Hitesh Deshmukh,Grace Guindani Vidal,Susan Macwana,John W. Kelly,X Kim,Brian A. Cobb,K Kaufman,S.-C. Bae,Betty P. Tsao,Nan Shen,Carl Langefeld,Théo Niewold,Gary Gilkeson,JT Merrill,Kathy L. Moser,John B. Harley,Samir Ranjan Nath,Peter Gaffney,J Dowling James,Joel M. Guthridge
DOI: https://doi.org/10.4049/jimmunol.182.supp.136.28
2009-01-01
Abstract:SLE is a complex autoimmune disease with immunological abnormalities that targets B cell functions and development. Previous genome-wide association studies identified C8orf13/BLK as a novel SLE risk factor. BLK (B lymphoid tyrosine kinase) has been shown to have potential effects on B cell develoment. The main objectives of this study are to: 1.) assess this association in independent populations and 2.) determine if BLK risk alleles correlate with alteration in peripheral blood B cell development and protein expression. We genotyped 52 SNPs within the C8orf13/BLK region in European-derived, Asian and African American populations. rs13277113 is associated with SLE in all three populations. A few novel upstream SNPs within the intergenic region demonstrate a stronger association in Asians. Flow cytometry data suggests there is a significant difference in BLK expression and T2 cells B cell numbers between high-risk and non-risk individuals based on the risk haplotype. Our results suggest that the BLK genetic polymorphisms alter immune system development and function to increase the risk for SLE development. Supported by NIH RR020143, RR015577, NIAID-DAIT-BAA-05-11, AI031584, AR053483, AR48940, AI063274, AR052125, AR043247 and OCAST # HR08-037.
What problem does this paper attempt to address?